Prostate-Specific Membrane Antigen (PSMA) Promotes Angiogenesis of Glioblastoma Through Interacting With ITGB4 and Regulating NF-κB Signaling Pathway
Open Access
- 4 March 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
Background Glioblastoma multiforme (GBM) is the most common primary malignant tumor in the central nervous system (CNS), causing the extremely poor prognosis. Combining the role of angiogenesis in tumor progression and the role of prostate-specific membrane antigen (PSMA) in angiogenesis, this study aims to explore the functions of PSMA in GBM. Methods Clinical GBM specimens were collected from 60 patients who accepted surgical treatment in Fudan University Shanghai Cancer Center between January 2018 and June 2019. Immunohistochemical staining was used to detect PSMA and CD31 expression in GBM tissues. Prognostic significance of PSMA was evaluated by bioinformatics. Human umbilical vein endothelial cells (HUVECs) transfected with PSMA overexpression plasmids or cultured with conditioned medium collected based on GBM cells, were used for CCK8, Transwell and tube formation assays. High-throughput sequencing and immunoprecipitation were used to explore the underlying mechanism. Furthermore, the in vivo experiment had been also conducted. Results We demonstrated that PSMA was abundantly expressed in endothelium of vessels of GBM tissues but not in vessels of normal tissues, which was significantly correlated with poor prognosis. Overexpression of PSMA could promotes proliferation, invasion and tube formation ability of human umbilical vein endothelial cells (HUVECs). Moreover, U87 or U251 conditioned medium could upregulated PSMA expression and induce similar effects on phenotypes of HUVECs, all of which could be partially attenuated by 2-PMPA treatment. The mechanistic study revealed that PSMA might promote angiogenesis of GBM through interacting with Integrin β4 (ITGB4) and activating NF-κB signaling pathway. The in vivo growth of GBM could be alleviated by the treatment of 2-PMPA. Conclusion This study identified PSMA as a critical regulator in angiogenesis and progression of GBM, which might be a promising therapeutic target for GBM treatment.This publication has 32 references indexed in Scilit:
- Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastasesCancer Cell International, 2014
- Prostate‐specific membrane antigen expression in tumor‐associated vasculature of breast cancersAPMIS, 2013
- Parathyroid hormone-related protein regulates integrin α6 and β4 levels via transcriptional and post-translational pathwaysExperimental Cell Research, 2013
- Bmi-1 Promotes Glioma Angiogenesis by Activating NF-κB SignalingPLOS ONE, 2013
- Prostate-Specific Membrane Antigen as a Potential Novel Vascular Target for Treatment of Glioblastoma MultiformeArchives of Pathology & Laboratory Medicine, 2011
- Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned mediumInternational Journal of Oncology, 2011
- The roles of integrin β4 in Vascular Endothelial CellsJournal of Cellular Physiology, 2011
- Modulation of vascular endothelial cell senescence by integrin β4Journal of Cellular Physiology, 2010
- Prostate-Specific Membrane Antigen Regulates Angiogenesis by Modulating Integrin Signal TransductionMolecular and Cellular Biology, 2006
- Targeted Deletion of the Integrin β4 Signaling Domain Suppresses Laminin-5-Dependent Nuclear Entry of Mitogen-Activated Protein Kinases and NF-κB, Causing Defects in Epidermal Growth and MigrationMolecular and Cellular Biology, 2005